Melinda J Gooderham (M J Gooderham, Melinda Gooderham, M Gooderham)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 102

Top Venues

Journal of cutaneous medicine and surgery

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatology and therapy

The British journal of dermatology

Queen's University (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Queen's University

Canada

BSC

University of Guelph

Canada

MSC :: Department of Biochemistry

Publications

Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Melinda J Gooderham, Ronald Vender, Jeffrey Crowley, H Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, Lawrence Green
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor). Dermatology and therapy 14 (2) (2024)
Annie George, Rafael Paolo Lansang, Perla Lansang, Melinda J Gooderham
A Practical Guide to Using Biologics in Pediatric Dermatology. Journal of cutaneous medicine and surgery (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology (2024)
Melinda J Gooderham, Ronald Vender, Jeffrey Crowley, H Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, Lawrence Green
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor). Dermatology and therapy (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Andreas Wollenberg, Melinda J Gooderham, Norito Katoh, Valeria Aoki, Andrew E Pink, Yousef Binamer, Jonathan Ian Silverberg
Patient-reported burden in adults with atopic dermatitis: an international qualitative study. Archives of dermatological research 316 (7) (2024)
Andreas Wollenberg, Melinda J Gooderham, Norito Katoh, Valeria Aoki, Andrew E Pink, Yousef Binamer, Jonathan Ian Silverberg
Patient-reported burden in adults with atopic dermatitis: an international qualitative study. Archives of dermatological research 316 (7) (2024)
Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV 38 (5) (2024)
Annie George, Rafael Paolo Lansang, Perla Lansang, Melinda J Gooderham
A Practical Guide to Using Biologics in Pediatric Dermatology. Journal of cutaneous medicine and surgery (2024)
Melinda J Gooderham, Ronald Vender, Jeffrey Crowley, H Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, Lawrence Green
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor). Dermatology and therapy 14 (2) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Chelsea Obeng-Asumeng, Fabian Rodriguez-Bolanos, Melinda J Gooderham
Real-World Experience of Vitiligo Patients: A Retrospective Chart Review. Journal of cutaneous medicine and surgery (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Norito Katoh, Valeria Aoki, Andrew E Pink, Yousef Binamer, Marius Rademaker, Daria Fomina, Jan Gutermuth, Ji Young Ahn, Fernando Valenzuela, Mahreen Ameen, Martin Steinhoff, Mark G Kirchhof, Peter A Lio, Andreas Wollenberg
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Carter Haag, Andrew Alexis, Valeria Aoki, Robert Bissonnette, Andrew Blauvelt, Raj Chovatiya, Michael J Cork, Simon G Danby, Lawrence Eichenfield, Kilian Eyerich, Melinda J Gooderham, Emma Guttman-Yassky, Dirk-Jan Hijnen, Alan Irvine, Norito Katoh, Dedee Frances Murrell, Yael A Leshem, Adriane Levin, Ida Vittrup, Jill I Olydam, Raquel L Orfali, Amy Paller, Yael Renert-Yuval, David Rosmarin, Jonathan Ian Silverberg, Jacob Thyssen, Sonja Ständer, Nick Stefanovic, Gail Todd, JiaDe Yu, Eric Simpson
A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council. The British journal of dermatology (2024)
Mark G Kirchhof, Vimal H Prajapati, Melinda J Gooderham, H Chih-Ho Hong, Charles W Lynde, Catherine Maari, Irina Turchin, Kim A Papp
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors. Dermatology and therapy (2024)
Andreas Wollenberg, Melinda J Gooderham, Norito Katoh, Valeria Aoki, Andrew E Pink, Yousef Binamer, Jonathan Ian Silverberg
Patient-reported burden in adults with atopic dermatitis: an international qualitative study. Archives of dermatological research 316 (7) (2024)
Annie George, Rafael Paolo Lansang, Perla Lansang, Melinda J Gooderham
A Practical Guide to Using Biologics in Pediatric Dermatology. Journal of cutaneous medicine and surgery 28 (1) (2024)
Richie Jeremian, Yuliya Lytvyn, Rayyan Fotovati, Kaiyang Li, Alexandra Malinowski, Muskaan Sachdeva, Carolyn Jack, Melinda J Gooderham, David O Croitoru, Jensen Yeung, Vincent Piguet
Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Melinda J Gooderham, Ronald Vender, Jeffrey Crowley, H Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, Lawrence Green
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor). Dermatology and therapy 14 (2) (2024)
Chelsea Obeng-Asumeng, Fabian Rodriguez-Bolanos, Melinda J Gooderham
Real-World Experience of Vitiligo Patients: A Retrospective Chart Review. Journal of cutaneous medicine and surgery 28 (2) (2024)
Chelsea Obeng-Asumeng, Fabian Rodriguez-Bolanos, Melinda J Gooderham
Real-World Experience of Vitiligo Patients: A Retrospective Chart Review. Journal of cutaneous medicine and surgery 28 (2) (2024)
Chelsea Obeng-Asumeng, Fabian Rodriguez-Bolanos, Melinda J Gooderham
Real-World Experience of Vitiligo Patients: A Retrospective Chart Review. Journal of cutaneous medicine and surgery 28 (2) (2024)
Andreas Wollenberg, Melinda J Gooderham, Norito Katoh, Valeria Aoki, Andrew E Pink, Yousef Binamer, Jonathan Ian Silverberg
Patient-reported burden in adults with atopic dermatitis: an international qualitative study. Archives of dermatological research 316 (7) (2024)
Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV 38 (5) (2024)
Vimal H Prajapati, Charles W Lynde, Melinda J Gooderham, H Chih-Ho Hong, Mark G Kirchhof, Perla Lansang, Julien Ringuet, Irina Turchin, Ronald B Vender, Jensen Yeung, Kim A Papp
Considerations for defining and diagnosing generalized pustular psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Annie George, Rafael Paolo Lansang, Perla Lansang, Melinda J Gooderham
A Practical Guide to Using Biologics in Pediatric Dermatology. Journal of cutaneous medicine and surgery 28 (1) (2024)
Chelsea Obeng-Asumeng, Fabian Rodriguez-Bolanos, Melinda J Gooderham
Real-World Experience of Vitiligo Patients: A Retrospective Chart Review. Journal of cutaneous medicine and surgery 28 (2) (2024)
Annie George, Rafael Paolo Lansang, Perla Lansang, Melinda J Gooderham
A Practical Guide to Using Biologics in Pediatric Dermatology. Journal of cutaneous medicine and surgery 28 (1) (2024)
Gil Yosipovitch, Melinda J Gooderham, Pamela Guglielmini, Luz Fonacier, Jacek Cezary Szepietowski, Mette Deleuran, Giampiero Girolomoni, John C Su, Andrew G Bushmakin, Joseph Christopher Cappelleri, Claire Feeney, Gary Chan, Andrew J Thorpe, Hernan Valdez, Pinaki Biswas, Ricardo Rojo, Marco daCosta DiBonaventura, Daniela E Myers
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2. American journal of clinical dermatology (2023)
Kim A Papp, Jennifer Beecker, Curtis L Cooper, Mark G Kirchhof, Anton L Pozniak, Juergen K Rockstroh, Jan P Dutz, Melinda J Gooderham, Robert Gniadecki, H Chih-Ho Hong, Charles W Lynde, Catherine Maari, Yves Poulin, Ronald B Vender, Sharon L Walmsley
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and therapy (2023)
Georgios Kokolakis, Richard Bruce Warren, Bruce E Strober, Andrew Blauvelt, Luis Puig, Akimichi Morita, Melinda J Gooderham, Andreas Körber, Veerle Vanvoorden, Maggie Wang, Dirk de Cuyper, Cynthia Madden, Natalie Nunez Gomez, Mark Lebwohl
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials. The British journal of dermatology 188 (3) (2023)
Peter Schmid-Grendlmeier, Melinda J Gooderham, Karin Hartmann, Konstantinou George, Marc Fellmann, Christopher Koulias, Claire Clibborn, Pinaki Biswas, Patrick M Brunner
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies. Allergy (2023)
Jacob Pontoppidan Thyssen, D Thaçi, T Bieber, Melinda J Gooderham, M de Bruin-Weller, W Soong, K Kabashima, Sébastien Barbarot, P C Luna, J Xu, X Hu, Y Liu, E M Raymundo, Brian M Calimlim, C Nduaka, A Gamelli, Eric L Simpson
Upadacitinib for moderate-to-severe atopic dermatitis: stratified analysis from three randomized phase 3 trials by key baseline characteristics. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Melinda J Gooderham, Andrew E Pink, Eric L Simpson, Jonathan Ian Silverberg, Erman Güler, Melissa Watkins
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice. Dermatology and therapy (2023)
Abrahim Abduelmula, Melinda J Gooderham
Long-Term Multiple Center Experience in Treating Plaque Psoriasis With Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion. Journal of cutaneous medicine and surgery (2023)
Ana Maria Lé, Melinda J Gooderham, Tiago Torres
Abrocitinib for the treatment of atopic dermatitis. Immunotherapy (2023)
Camille Hamm, Nusha Ramsoondar, Michaela McGillis, Miranda Waugh, Melinda J Gooderham, Lyne L Giroux
The Effectiveness of Risankizumab Following Guselkumab Failure in Moderate-to-Severe Psoriasis Patients: A Retrospective Study. Journal of cutaneous medicine and surgery (2023)
Lluis L Puig, Siew Eng Choon, Alice B Gottlieb, Slaheddine Marrakchi, Jörg C Prinz, Ricardo Romiti, Yayoi Tada, Dorothea von Bredow, Melinda J Gooderham
Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Georgios Kokolakis, Richard Bruce Warren, Bruce E Strober, Andrew Blauvelt, Luis Puig, Akimichi Morita, Melinda J Gooderham, Andreas Körber, Veerle Vanvoorden, Maggie Wang, Dirk de Cuyper, Cynthia Madden, Natalie Nunez Gomez, Mark Lebwohl
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials. The British journal of dermatology 188 (3) (2023)
Lluis L Puig, Siew Eng Choon, Alice B Gottlieb, Slaheddine Marrakchi, Jörg C Prinz, Ricardo Romiti, Yayoi Tada, Dorothea von Bredow, Melinda J Gooderham
Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. Journal of the European Academy of Dermatology and Venereology : JEADV 37 (4) (2023)
Lluis L Puig, Siew Eng Choon, Alice B Gottlieb, Slaheddine Marrakchi, Jörg C Prinz, Ricardo Romiti, Yayoi Tada, Dorothea von Bredow, Melinda J Gooderham
Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Lluis L Puig, Siew Eng Choon, Alice B Gottlieb, Slaheddine Marrakchi, Jörg C Prinz, Ricardo Romiti, Yayoi Tada, Dorothea von Bredow, Melinda J Gooderham
Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Maria K Hordinsky, Adelaide A Hebert, Melinda J Gooderham, Ohsang Kwon, Nikolay Murashkin, Hong Fang, Kazutoshi Harada, Ernest Law, Dalia Wajsbrot, Liza Takiya, Samuel H Zwillich, Robert Wolk, Helen Tran
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial. Pediatric dermatology (2023)
Melinda J Gooderham, Robert Bissonnette, Sunil Kalia, Kim A Papp, Lyn C Guenther, Wayne P Gulliver, Vincent Ho, Neil H Shear, Ronald B Vender, Robert Gniadecki, Vimal H Prajapati, Irina Turchin, Wayne Langholff, Kim A Papp, Scott D Simpson, Nastaran Abbarin, Omair Lakhani, Raed Alhusayen
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Journal of cutaneous medicine and surgery (2023)
Wayne Gulliver, Afsaneh Alavi, Marni C Wiseman, Melinda J Gooderham, Jaggi Rao, Maryam Shayesteh Alam, Kim A Papp, Olivier Desjardins, Christine Jean
Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With Adalimumab. Journal of cutaneous medicine and surgery 26 (4) (2022)
Melinda J Gooderham, Chih-Ho Hong
Practice Patterns Around the Management of Atopic Dermatitis in 2018 and 2020. Journal of cutaneous medicine and surgery 26 (5) (2022)
Melinda J Gooderham, Kim A Papp, Charles Lynde, Isabelle Delorme, Jennifer Beecker, Lorne Albrecht, Ignacio Dei-Cas, Danielle Brassard, Vimal H Prajapati, Antonio Vieira, Lenka Rihakova
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry. Dermatology and therapy (2022)
Anthony P Fernandez, Esteban Daudén, Sascha Gerdes, M G Lebwohl, M A Menter, C L Leonardi, Melinda J Gooderham, K Gebauer, Yayoi Tada, Jean-Philippe Lacour, L Bianchi, Alexander Egeberg, I Pau-Charles, A M Mendelsohn, S J Rozzo, Nehal N Mehta
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (10) (2022)
Melinda J Gooderham, Kim A Papp, Charles Lynde, Isabelle Delorme, Jennifer Beecker, Lorne Albrecht, Ignacio Dei-Cas, Danielle Brassard, Vimal H Prajapati, Antonio Vieira, Lenka Rihakova
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry. Dermatology and therapy (2022)
Hideki Fujita, Melinda J Gooderham, Ricardo Romiti
Diagnosis of Generalized Pustular Psoriasis. American journal of clinical dermatology 23 (Suppl 1) (2022)
Antoinette Chandler, Hannah Wood, Novin Nezamololama, Melinda J Gooderham
Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options. Journal of psoriasis and psoriatic arthritis 7 (3) (2022)
Brian D Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva, Asfandyar Mufti, Alim R Devani, Melinda J Gooderham, H Chih-Ho Hong, Vipul Jain, Perla Lansang, Ronald B Vender, Jensen Yeung, Vimal H Prajapati
Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study. The Journal of dermatological treatment 33 (5) (2022)
Georgios Kokolakis, Richard Bruce Warren, Bruce E Strober, Andrew Blauvelt, Luis Puig, Akimichi Morita, Melinda J Gooderham, Andreas Körber, Veerle Vanvoorden, Maggie Wang, Dirk de Cuyper, Cynthia Madden, Natalie Nunez Gomez, Mark Lebwohl
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials. The British journal of dermatology (2022)
Melinda J Gooderham, Kim A Papp, Charles Lynde, Isabelle Delorme, Jennifer Beecker, Lorne Albrecht, Ignacio Dei-Cas, Danielle Brassard, Vimal H Prajapati, Antonio Vieira, Lenka Rihakova
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry. Dermatology and therapy (2022)
Melinda J Gooderham, Kim A Papp, Charles Lynde, Isabelle Delorme, Jennifer Beecker, Lorne Albrecht, Ignacio Dei-Cas, Danielle Brassard, Vimal H Prajapati, Antonio Vieira, Lenka Rihakova
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry. Dermatology and therapy 13 (2) (2022)
Wayne P Gulliver, Melinda J Gooderham, Baojin Zhu, Christian Jossart, Sonia Montmayeur, Russel T Burge, Catherine Reed
Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program. Dermatology and therapy (2022)
Melinda J Gooderham, Andreas Pinter, L K Ferris, R B Warren, Tianyu Zhan, J Zeng, A M Soliman, C Kaufmann, B Kaplan, H Photowala, Bruce E Strober
Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (6) (2022)
Andrew Blauvelt, Melinda J Gooderham, Neal Bhatia, Richard G Langley, Shannon Schneider, John Zoidis, Azra Kurbasic, April Armstrong, Jonathan Ian Silverberg
Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3. Dermatology and therapy 12 (11) (2022)
Kim A Papp, Jennifer Beecker, Curtis L Cooper, Mark G Kirchhof, Anton L Pozniak, Juergen K Rockstroh, Jan P Dutz, Melinda J Gooderham, Robert Gniadecki, H Chih-Ho Hong, Charles W Lynde, Catherine Maari, Yves Poulin, Ronald B Vender, Sharon L Walmsley
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and therapy 12 (5) (2022)
S Ständer, N Bhatia, Melinda J Gooderham, Jonathan Ian Silverberg, Jacob Pontoppidan Thyssen, P Biswas, M DiBonaventura, W Romero, S A Farooqui
High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Athalia Voisin, Aya Al-Ali, Abrahim Abduelmula, Melinda J Gooderham
Reasons for the Termination of Interleukin-17 Inhibitor Medications in the Treatment of Plaque Psoriasis: A Real-World Retrospective Study. Journal of cutaneous medicine and surgery (2022)
Claire Chiang, Melinda J Gooderham
Achenbach Syndrome (Paroxysmal Finger Hematoma). Journal of cutaneous medicine and surgery 26 (5) (2022)
M Mehta, A O'Toole, Melinda J Gooderham
Real-world experience with risankizumab in patients with plaque psoriasis: a retrospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (10) (2021)
Baldwin C Mak, Bryan T Addeman, Jia Chen, Kim A Papp, Melinda J Gooderham, Lyn C Guenther, Yi Liu, Uli C Broedl, Marianne E Logger
Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot. Blockchain in healthcare today 4 (2021)
Suzanne Murray, Jeffrey Crowley, Melinda J Gooderham, Alan Kivitz, Vinod Chandran, Sophie Péloquin, Paul P Doghramji, Christie Freeman, Patrice Lazure
Healthcare Providers Face Numerous Challenges in Treating Patients with Psoriasis: Results from a Mixed-Methods Study. Journal of psoriasis and psoriatic arthritis 7 (1) (2021)
Hannah Wood, Antoinette Chandler, Novin Nezamololama, Kim Papp, Melinda J Gooderham
Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis. International journal of dermatology (2021)
M Logel, R Pammett, C Chiang, A O'Toole, Melinda J Gooderham
The effectiveness of intralesional Candida antigen immunotherapy as a treatment for anogenital warts: a retrospective chart review. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Melinda J Gooderham, Mawiyah Haq, Jennifer Beecker, Ashley O'Toole
Lymantria dispar dispar (Gypsy) Moth Dermatitis. Journal of cutaneous medicine and surgery 25 (5) (2021)
Baldwin C Mak, Bryan T Addeman, Jia Chen, Kim A Papp, Melinda J Gooderham, Lyn C Guenther, Yi Liu, Uli C Broedl, Marianne E Logger
Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot. Blockchain in healthcare today 4 (2021)
Mawiyah Haq, Ashley O'Toole, Jennifer Beecker, Melinda J Gooderham
Return of Lymantria dispar dispar (gypsy moth): A case report. SAGE open medical case reports 9 (2021)
Meghan L McPhie, William C Swales, Melinda J Gooderham
Improvement of granulomatous skin conditions with tofacitinib in three patients: A case report. SAGE open medical case reports 9 (2021)
Kim A Papp, Robert Gniadecki, Jennifer Beecker, Jan Dutz, Melinda J Gooderham, Chih-Ho Hong, Mark G Kirchhof, Chuck W Lynde, Catherine Maari, Yves Poulin, Ronald B Vender
Psoriasis Prevalence and Severity by Expert Elicitation. Dermatology and therapy 11 (3) (2021)
Milica Milakovic, Melinda J Gooderham
Phosphodiesterase-4 Inhibition in Psoriasis. Psoriasis (Auckland, N.Z.) 11 (2021)
Abrahim Abduelmula, Melinda J Gooderham
TYK2 inhibition: changing the treatment landscape for psoriasis? Expert review of clinical immunology (2021)
Madison Ward, Khalad Maliyar, Melinda J Gooderham
A case report of recalcitrant aphthous ulcers in two patients treated with interleukin-17 inhibitors. SAGE open medical case reports 9 (2021)
Rauno J Harvima, Melinda J Gooderham, Stephen Tyring, Henrik Thoning, Nanna Nyholm, Linda Stein Gold
Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis in Finland. The Journal of dermatological treatment (2021)
Jennifer Beecker, Kim A Papp, J Dutz, Ronald B Vender, Robert Gniadecki, Curtis L Cooper, Paolo Gisondi, Melinda J Gooderham, C H Hong, M G Kirchhof, C W Lynde, C Maari, Y Poulin, Lluis L Puig
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (4) (2021)
Kim A Papp, Melinda J Gooderham, L E Albrecht, M-A Raymond, C W Lynde
Treatment satisfaction, safety, and effectiveness of adding methotrexate to adalimumab in psoriasis patients responding sub-optimally to adalimumab in a real-world setting. The British journal of dermatology (2021)
Ahmad Jalili, Piergiacomo Calzavara-Pinton, L Kircik, D Lons-Danic, Andrew E Pink, S Tyring, Pablo de la Cueva-Dobao, Melinda J Gooderham, Siegfried Segaert, N Nyholm, H Thoning, B Petersen, D Thaçi
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Craig Leonardi, Kristian Reich, Peter Foley, Hideshi Torii, Sascha Gerdes, Lyn C Guenther, Melinda J Gooderham, Laura K Ferris, Christopher E M Griffiths, Hany ElMaraghy, Heidi Crane, Himanshu Patel, Russel Burge, Gaia Gallo, David Shrom, Ann Leung, Chen-Yen Lin, Kim A Papp
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials. Dermatology and therapy 10 (3) (2020)
Andrew Blauvelt, C Leonardi, Boni E Elewski, J J Crowley, L C Guenther, Melinda J Gooderham, R G Langley, Ronald B Vender, Andreas Pinter, C E M Griffiths, Y Tada, H Elmaraghy, R G Lima, G Gallo, L Renda, Russel T Burge, S Y Park, B Zhu, Kim A Papp, null null
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial. The British journal of dermatology 184 (6) (2020)
Siegfried Segaert, Piergiacomo Calzavara-Pinton, Pablo de la Cueva-Dobao, Ahmad Jalili, Dominique Lons Danic, Andrew E Pink, Diamant Thaçi, Melinda J Gooderham
Long-term topical management of psoriasis: the road ahead. The Journal of dermatological treatment (2020)
Kristy C Metzger, Erika L Crowley, Dorota Kadlubowska, Melinda J Gooderham
Uncommon Adverse Effects of Deoxycholic Acid Injection for Submental Fullness: Beyond the Clinical Trials. Journal of cutaneous medicine and surgery 24 (6) (2020)
Jensen Yeung, Melinda J Gooderham, Parbeer S Grewal, Chih-Ho Hong, Perla Lansang, Kim A Papp, Yves Poulin, Irina Turchin, Ronald B Vender
Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper. Journal of cutaneous medicine and surgery 24 (1_suppl) (2020)
Novin Nezamololama, Erika L Crowley, Melinda J Gooderham, Kim A Papp
Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis. Expert opinion on investigational drugs 29 (9) (2020)
Khalad Maliyar, Ashley O'Toole, Melinda J Gooderham
Long-Term Single Center Experience in Treating Plaque Psoriasis With Guselkumab. Journal of cutaneous medicine and surgery 24 (6) (2020)
Chih-Ho Hong, Melinda J Gooderham, Robert Bissonnette
Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis. Journal of cutaneous medicine and surgery 23 (4_suppl) (2020)
Erika L Crowley, Novin Nezamololama, Kim Papp, Melinda J Gooderham
Abrocitinib for the treatment of atopic dermatitis. Expert review of clinical immunology 16 (10) (2020)
Zainab Ridha, Lydia Ouchene, Elena Netchiporouk, Melinda J Gooderham
Topical PDE-4 Inhibitors are Emerging for Psoriasis Treatment. Journal of cutaneous medicine and surgery 25 (1) (2020)
Melinda J Gooderham, Abby S Van Voorhees, Mark G Lebwohl
An update on generalized pustular psoriasis. Expert review of clinical immunology 15 (9) (2019)
Lluis L Puig, Jashin J Wu, Melinda J Gooderham, Yin You, Yaung-Kaung Shen, Bruce Randazzo, Francisco Kerdel
Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2. The Journal of dermatological treatment 32 (5) (2019)
Khalad Maliyar, Erika L Crowley, Fabian Rodriguez-Bolanos, Ashley O'Toole, Melinda J Gooderham
The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review. Journal of cutaneous medicine and surgery 23 (4) (2019)
A B Kimball, Kim A Papp, K Reich, Melinda J Gooderham, Q Li, N Cichanowitz, C La Rosa, Andrew Blauvelt
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies. The British journal of dermatology 182 (6) (2019)
Erika L Crowley, Shamone C Fine, Kathleen Kwan Katipunan, Melinda J Gooderham
The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature. Journal of cutaneous medicine and surgery 23 (3) (2019)
Kim A Papp, C Maari, A Cauthen, Melinda J Gooderham, Lynda Spelman, Keiichi Yamanaka, P Polzer, L Zhang, O Osuntokun, Matthias Augustin
An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12. The British journal of dermatology 183 (1) (2019)

Melinda J Gooderham.css-eqlu8i{font-size:small;padding-left:4px;} (M J Gooderham, Melinda Gooderham, M Gooderham)

Publication Activity (10 Years)

Top Topics

Top Venues

Melinda J Gooderham (M J Gooderham, Melinda Gooderham, M Gooderham)